Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests if teaching patients and doctors to spot skin cancer early can save lives after transplant

NCT ID NCT04358276

Knowledge-focused Sponsor: City of Hope Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether teaching stem cell transplant survivors and their primary care doctors about skin cancer screening can lead to earlier detection. Participants receive educational materials and some doctors get a dermatoscope (a magnifying lens). The goal is to see if these tools help people notice suspicious moles sooner and get them checked faster. 840 survivors are taking part.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Educational program and dermatoscope
What this could lead to
If successful, this could show that simple education and a dermatoscope help catch skin cancer earlier in transplant survivors, potentially improving outcomes.
What could go wrong
This is an observational/educational study, not testing a new drug or cure. It may not change screening rates or catch cancers earlier in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

840 people

The number who actually took part.

Started

Oct 2020

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have undergone autologous or allogeneic hematopoietic stem cell transplantation (HCT) at City of Hope (COH) * Are 2 years (yrs) to 5 yrs (+/- 3 months \[m\]) after HCT * Have seen a primary care provider (PCP) in the previous 12 m (expected \> 95% of all eligible) or planning to do so in next 12 m * Have a mobile phone with the ability to receive text messages * Can fluently read and write in English or Spanish * Can understand and sign the study-specific Informed Consent Form (ICF) Exclusion Criteria: * Patients who have evidence of active hematologic malignancy or acute illness that would limit study participation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Skin carcinoma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin carcinoma skin cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Skin carcinoma

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.